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Abstract
Background—The Centers for Medicare and Medicaid Services is considering developing a 30-
day ischemic stroke hospital-level mortality model using administrative data. We examined
whether inclusion of the NIH Stroke Scale (NIHSS), a measure of stroke severity not included in
administrative data, would alter 30-day mortality rates in the Veterans Health Administration
(VHA).
Methods—2562 veterans admitted with ischemic stroke to 64 VHA Hospitals in fiscal year 2007
were included. First, we examined the distribution of unadjusted mortality rates across the VHA.
Second, we estimated 30-day-all-cause-risk standardized-mortality rates (RSMR) for each hospital
by adjusting for age, gender and comorbid conditions using hierarchical models with and without
inclusion of the NIHSS. Finally, we examined whether adjustment for the NIHSS significantly
changed RSMRs for each hospital compared to other hospitals.
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Results—The median unadjusted mortality rate was 3.6%. The RSMR inter-quartile range
without the NIHSS ranged from 5.1% to 5.6%. Adjustment with the NIHSS did not change the
RSMR inter-quartile range (5.1% to 5.6%). Among veterans ≥ 65 years, the RSMR inter-quartile
range without the NIHSS ranged from 9.2% to 10.3%. With adjustment for the NIHSS, the RSMR
inter-quartile range changed to 9.4% to 10.0%. The plot of 30-day RSMRs estimated with and
without the inclusion of the NIHSS in the model demonstrated overlapping 95% confidence
intervals across all hospitals, with no hospital significantly below or above the mean unadjusted
30-day mortality rate. The 30-day mortality measure did not discriminate well among hospitals.
Conclusions—The impact of the NIHSS on RSMRs was limited. The small number of stroke
admissions and the narrow range of 30-day stroke mortality rates at the facility level in the VHA
cast doubt on the value of using 30-day RSMRs as a means of identifying outlier hospitals based
on their stroke care quality.
Keywords
stroke; outcome assessment (health care); hospital mortality
Introduction
To evaluate hospital quality, the Centers for Medicare and Medicaid Services (CMS) have
developed standardized methods using administrative data to report hospital condition
specific 30-day mortality rates.1-3 Currently, hospital data on 30-day mortality for patients
with pneumonia, congestive heart failure and acute myocardial infarction are available on
the CMS hospital compare website.4 One measure under consideration by CMS is a 30-day
hospital-level acute ischemic stroke mortality measure using administrative data. However,
serious concerns were raised against this proposal during the public comment period
arranged by CMS. 5 Both the American Academy of Neurology and the American Heart
Association expressed their opposition to the development of a 30-day acute ischemic stroke
mortality measure using only administrative data. 5 These organizations and many
physicians and hospital administrators expressed doubts over whether administrative data
could be used to adequately risk-adjust differences in case-mix between hospitals. Chief
among the concerns regarding risk adjustment was the absence of any validated measure of
stroke severity in the administrative data or in the chart review data used as part of the
measure development process. Many hospital administrators were concerned that patients
with severe strokes would be more likely to be diverted to their hospital because of regional
specialization in stroke care and a 30-day mortality model based on administrative data
alone would make their hospital appear to have a higher standardized 30-day mortality rate
compared to other hospitals. The National Institutes of Health Stroke Scale (NIHSS) is a
widely used, validated measure of stroke severity and is a predictor of both post-stroke
functional outcomes 6-8 and mortality.9-10 The development of a 30-day risk adjusted
mortality model without the inclusion of the NIHSS or other validated measure of stroke
severity might constitute a systematically-flawed measurement system leading to erroneous
conclusions by policymakers and the public.
The development of 30-day mortality measures to compare the performance of hospitals has
also been an area of interest to the Veterans Health Administration (VHA). In 2007 the
VHA Office of Quality and Performance (OQP) in partnership with the VHA Stroke Quality
Enhancement Research Initiative (QUERI) undertook a comprehensive review of VHA
ischemic stroke care quality; we used these national VHA data to assess the importance of
including the NIHSS in a 30-day mortality model that generates adjusted mortality rates to
compare VA hospital performance and to examine whether 30-day mortality could be used
as a means of ranking hospitals based on their stroke care quality.
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Methods
Sample
A sample of 5000 veterans admitted to a VA hospital in fiscal year 200711 (FY07) with a
primary discharge diagnosis of ischemic stroke was identified from VHA administrative
data using a modified high specificity algorithm of International Classification of Disease
Codes, 9th revision.12 The sample included all veterans at small volume centers (≤55
patients in FY07) and an 80% random sample of veterans at high volume centers (>55
patients in FY07). Data were collected through retrospective chart review of medical records
performed by abstractors from the West Virginia Medical Institute who were specially
trained for this study. A total of 1013 patients were excluded because: they had a carotid
endarterectomy during the stroke hospitalization; the stroke occurred after admission; they
had a transient ischemic attack rather than a stroke and/or they were admitted only for post-
stroke rehabilitation. To be consistent with current CMS measure specifications for 30-day
acute ischemic stroke mortality13 the sample was further restricted to exclude hospitals with
fewer than 25 stroke patients and patients transferred from other hospitals, leaving a final
sample of 2562 patients from 64 hospitals. In a secondary analysis, we excluded veterans
younger than 65 years to attain a sample that is more relevant to CMS policymakers,
providing 543 veterans across 17 hospitals for this analysis.
Variables
Our main dependent variable was 30-day stroke mortality defined as death from any cause
within 30 days after the index admission date. Mortality was assessed from the VA Vital
Status Files (VSF), which identifies VA beneficiary deaths from a variety of VA and non-
VA sources (e.g., CMS). Previous reports indicate that the VA VSF is relatively complete
and accurate when compared with information contained in the National Death Index (NDI),
the typical “gold standard” for death ascertainment. More than 98.3% of deaths in the VA
VSF were confirmed with deaths in the NDI.14 Our main independent variable was the
NIHSS which was retrospectively constructed from physician notes within 24 hours of
admission using trained abstractors. Similar to prior work, we used the following cutoffs for
the NIHSS (0-2, 3-5, 6-10, 11-15, 16-20, 21-25, >25).9 Covariates included age, gender, and
comorbid conditions available for each veteran. Comorbid conditions abstracted from the
medical record included a past history of hypertension, hyperlipidemia, diabetes mellitus,
coronary artery disease, acute myocardial infarction, coronary artery bypass graft,
percutaneous transluminal coronary angiography, transient ischemic attack or ischemic
stroke, intracranial hemorrhage or prior hemorrhagic stroke, any intracranial surgery or
carotid intervention, congestive heart failure, atrial fibrillation, chronic obstructive
pulmonary disease, peripheral vascular disease, kidney disease, dialysis, dementia,
depression, deep venous thrombosis, HIV, cancer, liver disease, any rheumatologic disorder,
and a history of gastrointestinal or genitourinary hemorrhage.
Analyses
Patient-level-analysis—While the focus of this study was to compare 30-day hospital-
level mortality rates, we first verified that the NIHSS was an important independent patient-
level predictor of 30-day mortality rates in our sample of patients using logistic regression
and adjusting for age, gender and comorbid conditions. We also determined the incremental
impact of adding the NIHSS on the C-statistic of the model that included only age, gender
and comorbid conditions.
Hospital-level-analysis—We examined the distribution of patient demographic and
clinical characteristics at the hospital level reporting the median and range across hospitals.
We calculated the mean, median and inter-quartile range for the observed unadjusted
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mortality rates across the 64 hospitals. Using the approach developed by CMS and endorsed
by the National Quality Forum4, we calculated hospital-specific risk standardized mortality
rates (RSMR) for each hospital. The CMS method estimates hospital-level 30 day all cause
risk standardized rates using a hierarchical logistic regression model to account for the
clustering of patients within hospitals and sample size variations among hospitals. The
model calculates the risk standardized mortality rate, by producing a ratio of the number of
“predicted” deaths to the number of “expected” deaths and multiplying by the national
unadjusted mortality rate.1, 4 Hospitals are then classified as better, worse, or no different
from the national average based on whether the 95% CI is higher, lower, or overlaps the
mean national unadjusted rate. Using this method,4 we calculated RSMRs for each hospital
and examined the mean, median and inter-quartile range across the VHA. We then
developed two hierarchical models, one which included age, gender and comorbid
conditions and one that included these variables, but also included the NIHSS and then used
these models to calculate the RSMR for each hospital.
To examine the impact of the NHISS as an additional adjuster, we performed several
analyses comparing the RSMRs estimated with and without inclusion of the NIHSS. First,
we plotted the RSMR and the associated 95% confidence interval for each hospital in all
patients with and without inclusion of the NIHSS to examine whether mortality rates
significantly changed for each hospital and relative to other hospitals. We did not examine
the impact of NIHSS on hospital rankings in patient above age 65 because the small volume
prohibited any meaningful comparisons. Second, we calculated Pearson’s r and Spearman’s
Rho to assess the correlation between the RSMRs estimated from the two models. Third, we
examined the correlations between facility mean NIHSS scores and their observed mortality
rates and RSMR excluding NIHSS and RSMR with NIHSS as an adjuster.
Sensitivity Analysis in estimating 30-day RSMRs—The RSMR methodology is
meant to deal with statistical estimation error as well as case-mix differences between
hospitals.1 Given the relatively small patient volume at each hospital, statistical estimation
error is of potential concern. We conducted a sensitivity analysis to assess the incremental
impact of the adjuster variables of age, gender, and comorbid conditions by comparing the
RSMRs estimated with the hierarchical models after adjusting for the covariates of interest
with alternative 30-day hospital mortality rates estimated with the RSMR methodology but
without the adjuster variables. All analyses were conducted using SAS Software, version 9.2
(SAS Institute, Inc., Cary, NC).
Results
Patient-level Characteristics and Model
A total of 2562 patients met the inclusion criteria. The median age for the entire sample of
veterans was 66 years (patient-level data not included in tables). About half the population
(50.5%) had an NIHSS of ≤2 suggesting low stroke severity for most of the patients. Only
8.2% of the population had an NIHSS of ≥ 11. The mean NIHSS in the sample was 2 with
an inter-quartile range of 1 to 5. Among veterans ≥ 65, the mean NIHSS was 3 with an inter-
quartile range of 2 to 6
We first demonstrated in our sample that at the patient-level, the NIHSS was an important
independent predictor of 30-day mortality. Patients older than 65 had over a twofold
increased odds in 30-day mortality compared to patient under 65 [odds ratio 2.4, 95% CI
(1.5-3.8)] and patients with NIHSS of greater than 25 had a 59 fold higher odds of mortality
compared with patients with an NIHSS ranging from 0-2 [odds ratio 59.2, 95% CI
(26.2-133.5)]. Two other patient factors that were associated with 30-day mortality: a history
of coronary artery disease and/or acute myocardial infarction [odds ratio 1.7, 95% CI
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(1.1-2.5)] and a history of cancer [odds ratio 2.2, 95% CI (1.3-3.6)]. None of the remaining
comorbid conditions was significantly associated with 30-day stroke mortality. The addition
of the NIHSS to the CMS model increased the C-statistic from 0.75 to 0.83 (patient-level
data not shown).
Population Characteristics across Different Hospitals
A total of 2562 patients across 64 hospitals met the inclusion criteria outlined by CMS. The
hospital-level median age for the entire sample of veterans was 67.6 with a range of 61.5 to
75.4 (Table 1). The sample was majority male, which is typical of the veteran population.
There was considerable variation in the median percent with a particular comorbidity at each
of hospital (Table 1). Hypertension was the most prevalent condition with a median
prevalence of 79%. Hyperlipidemia, diabetes and coronary artery disease were also common
conditions across Hospitals. The NIHSS varied with a hospital-level median of 3.8 across all
hospitals ranging from 0.8 to 6.8. On average each hospital admitted 37 patients (range 25 to
97) with 15 hospitals admitting greater than 80 stroke patients in FY07 (Table 2). The mean
unadjusted mortality rate was 5.1% [95% CI (4.0% - 6.2%)]. The median unadjusted
mortality rate was 3.6% [inter-quartile range (2.4% - 7.5%)] with a range of 0 to 17.8%
(Table 2).
30-day RSMRs across Hospitals
After adjustment for age and comorbid conditions the RSMR across the VHA changed to
5.40% [95% CI (2.65% - 9.60%)]. Addition of the NIHSS (categorized as 0-2, 3-5, 6-10,
11-15, 16-20, 21-25, >25) to a model including age, gender and comorbid conditions did not
appreciably change the mean adjusted mortality rate [5.42% 95% CI (2.52% - 9.92%)]; The
RSMR inter-quartile range without the NIHSS ranged from 5.1% to 5.6%; and ranged from
5.1% to 5.6% after inclusion of the NIHSS. Figure 1 displays the very small difference in
adjusted rates with or without the NIHSS.
Among veterans m=ge 65 years, the mean unadjusted mortality rate was higher than that of
the entire VA sample [8.8%, 95% CI (5.4% - 12.1%)] (Table 2). After adjustment for age
and comorbid conditions, the mean RSMR increased to 9.8% [95% CI (3.1% - 21.9%)].
Again, inclusion of the NIHSS in the 30-day mortality model did not appreciably change the
mean RSMR [9.8%, 95% CI (3.2% - 21.4%)] in this older population.
Impact of the NIHSS on Comparisons of 30-day RSMRs among All Hospitals
To examine whether there was any difference in 30-day RSMRs across hospitals and
whether inclusion of the NIHSS had an impact on these differences, we plotted the 30-day
RSMRs estimated with and without the inclusion of the NIHSS in the model. Figure 2
demonstrates overlapping 95% confidence intervals across all hospitals, with no hospital
significantly below or above the mean unadjusted 30-day mortality rate. The 30-day
mortality measure did not discriminate well among hospitals. The RSMRs from the two
methods were highly correlated: the Pearson’s correlation was .940 (p < .001) and the
Spearman’s Rho was .933 (p < .001). Finally, we found a modest correlation (r= .369 (p < .
01) between facility mean NIHSS scores and their observed mortality rates. Before adjusting
the RSMRs for the NIHSS, the correlation between facility RSMRs and their NIHSS scores
remained modest (r=.371, p < .01); after adjusting the RSMRs for NIHSS, the correlation
became non-significant. Thus, the stroke severity of patients accounted for some additional
variation in facility mortality rates but the effect was not strong enough to make a
substantive difference in the RSMR rates.
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Sensitivity Analysis
We assessed the incremental impact of the adjuster variables of age, gender, and comorbid
conditions by comparing the 30-day hospital-level RSMRs with alternative 30-day hospital
mortality rates. These alternative hospital mortality rates were estimated with the RSMR
methodology but without the adjuster variables (null model, figure 1). The confidence
intervals and inter-quartile ranges from these alternative rates were different from the
observed rates but very close to the RSMRs. The alternative 30-day hospital-level RSMR
for the total sample had a mean of 5.3% and inter-quartile range of 4.3% to 5.9%.
Discussion
We confirmed that the NIHSS is an important patient-level characteristic associated with 30-
day mortality. 9-10 The addition of the NIHSS to the CMS-like adjustment models increased
model discrimination. However, we also found that the addition of the NIHSS to a model
that includes age, gender and comorbid conditions did not alter the hospital-level 30-day
mortality rates in the VHA. The small number of stroke admissions and the narrow range of
30-day stroke mortality rates at the facility level in the VHA cast doubt on the value of using
30-day RSMRs as a means of identifying outlier hospitals in terms of stroke care quality. If
the VA were to follow the same methodology used by CMS Hospital Compare to report 30-
day ischemic stroke mortality, then all 64 VA hospitals would receive the same rank – “no
different from national rate” - whether NIHSS was included or not. However, data from the
national Office of Quality and Performance Study on stroke care in the VA demonstrates
that there are significant differences across the VA in Stroke quality process of care.11 The
power to detect differences in mortality in this study may not be adequate irrespective of risk
adjustment methods used.
Our limited sample of patients 65 and older precludes our ability to provide any insight on
the relative importance of including the NIHSS in the CMS 30-day acute ischemic stroke
mortality model. We did observe a modest improvement in model discrimination that could
suggest NIHSS may be important to hospital level comparisons. However, overall our
findings may not apply to clinical settings outside the VHA. There is less variation in 30-day
stroke mortality among veterans even those 65 and older in the VHA compared to the
Medicare population. The mean 30-day mortality rates reported in Medicare hospitals that
participate in the Get-with-the-Guidelines (GWTG) Stroke Program is 13.9% and is higher
than the mean 30-day mortality rate in veterans≥ 65 (8.8%).15 Among the 1036 hospitals
that participated in the GWTG Stroke Program, the mean NIHSS among stroke patients was
higher than our sample of patients ≥ 65 (mean NIHSS of 5 vs. 3). However, hospitals that
participate in the GWTG Stroke Program are particularly interested in stroke care and may
serve a population that is not nationally representative either. The NIHSS may have a greater
role in a system of care with greater variation in stroke severity such as the Medicare
program. A larger study of a cross-section of different types of hospitals across the US
should be undertaken to conclusively evaluate the impact of the NIHSS when comparing
facility performance in the Medicare program.
Our study has a number of important limitations that deserve comment. First, we used
medical record data and not administrative data in our analysis of the impact of the NIHSS
on hospital RSMRs. Any extrapolation of our results to models that use administrative data
must be made cautiously. Second, our analysis is based on a predominantly male cohort
which may limit the generalizability of our findings. Third, our main independent variable,
the NIHSS, was constructed retrospectively from physician notes. However, previous
studies have shown that the summed score of the retrospective NIHSS is very highly
correlated with the prospective NIHSS.16 Finally, our small sample size and limited facility
Keyhani et al. Page 6
Circ Cardiovasc Qual Outcomes. Author manuscript; available in PMC 2013 January 03.
$watermark-text
$watermark-text
$watermark-text
specific volume although in line with CMS guidelines on inclusion of facilities with greater
than 25 patients 13 may have diminished our ability to examine the impact of the NIHSS.
Summary
The limited influence of the NIHSS on 30-day mortality that we observed may be influenced
by the sample size and the narrow range of variability in both 30-day mortality and stroke
severity across the VHA. The NIHSS may have a greater role in adjusting facility-level
mortality rates in a system of care with greater variation in stroke severity and/or mortality
(such as the Medicare program); or in a system with more stroke admissions per hospital or
in which mortality is reported over a longer time frame. A larger study of a cross-section of
different types of hospitals across the US is needed to conclusively evaluate the impact of
the NIHSS when comparing facility performance in the Medicare program.
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Figure 1.
Risk Standardized 30-day mortality rates with and without inclusion of the NIH stroke scale
compared to the raw unadjusted mortality rates and the null model (model without any
covariates).
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Figure 2.
Risk Standardized 30-day mortality rates and 95% confidence Interval with and without
inclusion of the NIH stroke scale in the hierarchical model (all veterans).
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Table 1
Population Characteristics across Hospitals
Hospital Sample
Includes All
Veterans
Hospital Sample
Includes
Veterans ≥ 65
No. Hospitals 64 17
No. Patients 2562 543
Hospital Median age, yrs (range) 67.6 (61.5-75.4) 76.5 (73.4-80.1)
Male, median % (range) 98 (88-100) 100 (90-100)
Comorbid Conditions Median % (range)
Hypertension 79 (52-98) 50 (20-78.8)
Hyperlipidemia 50 (11-72) 36.6 (16-62.9)
Diabetes Mellitus 41 (9-66) 0 (0-5.9)
Coronary artery disease , acute myocardial infarction,
coronary artery bypass graft or percutaneous transluminal
coronary angiography
33 (8-62) 37.0 (22.9-66.7)
Prior ischemic stroke or transient ischemic attack 28 (0-53) 34.6 (0-44)
Depression 16 (0-39) 0 (0 –9.1)
Atrial fibrillation 15 ( 4 -29) 87.9 (69.7-96)
Chronic obstructive pulmonary disease or asthma 13 (0-46) 15.9 (3.2-29.6)
Congestive heart failure 11 (0-29) 14.3 (4-27.3)
Peripheral vascular disease 8 (0-24) 10.3 (0-14.7)
Cancer 7(0 -19) 0 (0 -3.8)
Dementia 7 (0-24) 12.1 (7.3-25)
Any intracranial surgery or carotid Intervention 4 (0 -24) 6.5 (0 -33.3)
Intracranial hemorrhage or prior hemorrhagic stroke 0 (0-18) 0 (0-6.5)
Kidney disease requiring dialysis or dialysis in past 7 days* 0 (0-7) 14.8 (4-25.7)
HIV 0 (0 -11) 9.7 (0 –22.2)
Deep venous thrombosis or pulmonary embolism 0 (0 - 9) 0 (0 - 0)
Liver disease 0 (0 -13) 0 (0 - 4)
Rheumatologic disorder (systemic lupus erythematosus or
vasculitis)
0 (0 - 5) 20 ( 8 –39.4)
Active internal bleeding gastrointestinal or genitourinary
bleeding within past 21 days *
0 (0-17) 0 (0-20.7)
Serious head injury in past 3 months* 0 (0-4) 0 (0-3.4)
NIH Stroke Scale (hospital-level median and range) 3.8 (0.8-6.8) 4.9 (2.5-7.7)
*
Three of the variables were collected as part of the OQP stroke special project to assess the appropriateness of thrombolytic therapy. This explains
the time window given to some of the variables.
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Table 2
Distribution of Unadjusted and Risk Standardized Mortality across Hospitals
Hospital Characteristics
Hospital Sample
Includes All Veterans
Hospital Sample Includes
Veterans ≥ 65
 No. Patients 2562 543
 No. Hospitals 64 17
 Median patients
 per hospital (range) 37 (25-97) 29 (25-52)
Observed (Unadjusted) Mortality
Rate
Mean Mortality Rate and 95% CI 5.1% (4.0% -6.2%) 8.8% (5.4% -12.1%)
Median and (IQR, 25%, 75%) 3.6% (2.4%, 7.5%) 8% (3.8%, 11.1%)
Range (min-max) 0 -17.8% 0 –21.2%
RSMR without Inclusion of
NIHSS in Model
Mean RSMR and 95% CI 5.40% (2.65%-9.60%) 9.84% (3.09% -21.9%)
Median and (IQR, 25%, 75%) 5.35 (5.1%-5.6%) 10.04% (9.24% -10.27%)
Range (min-max) 4.79%-6.82% 6.86-12.09%
RSMR with Inclusion of NIHSS
in Model
Mean RSMR and 95%CI 5.42% (2.52%-9.92%) 9.75% (3.16% -21.38%)
Median and (IQR, 25%, 75%) 5.24% (5.1%-5.6%) 9.90% (9.40% -10.04%)
Range (min-max) 4.72%-6.81% 7.53% -11.58%
The cohort included a sample of all veterans at small volume centers (≤55 patients in fiscal year 2007) and an 80% random sample of veterans at
high volume centers (>55 patients in fiscal year 2007).
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